{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:08Z","timestamp":1792783748517,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31300974"],"award-info":[{"award-number":["31300974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870140"],"award-info":[{"award-number":["31870140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities of China","doi-asserted-by":"publisher","award":["N142005001"],"award-info":[{"award-number":["N142005001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities of China","doi-asserted-by":"publisher","award":["N172002001"],"award-info":[{"award-number":["N172002001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Revitalization Talents Program","award":["XLYC1807001"],"award-info":[{"award-number":["XLYC1807001"]}]},{"name":"Shenyang high-level innovative talents program","award":["RC180347"],"award-info":[{"award-number":["RC180347"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.colsurfb.2019.110446","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T11:28:23Z","timestamp":1566300503000},"page":"110446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice"],"prefix":"10.1016","volume":"183","author":[{"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baocheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixiang","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9195-2255","authenticated-orcid":false,"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.colsurfb.2019.110446_bib0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Disease","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.colsurfb.2019.110446_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/EC.05273-11","article-title":"Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence","volume":"11","author":"Kronstad","year":"2012","journal-title":"Eukaryot. Cell"},{"issue":"2","key":"10.1016\/j.colsurfb.2019.110446_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.colsurfb.2019.110446_bib0020","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1473-3099(17)30303-1","article-title":"Fungal infections in HIV\/AIDS","volume":"17","author":"Limper","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.colsurfb.2019.110446_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-10-199","article-title":"A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease","volume":"10","author":"Chau","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.colsurfb.2019.110446_bib0035","doi-asserted-by":"crossref","first-page":"e1004285","DOI":"10.1371\/journal.ppat.1004285","article-title":"Cryptococcus gattii VGIII isolates causing infections in HIV\/AIDS patients in Southern California: identification of the local environmental source as arboreal","volume":"10","author":"Springer","year":"2014","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.colsurfb.2019.110446_bib0040","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/IAI.68.7.4225-4237.2000","article-title":"Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection","volume":"68","author":"Feldmesser","year":"2000","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.colsurfb.2019.110446_bib0045","first-page":"871","article-title":"Cryptococcus neoformans survive and replicate in human microglia","volume":"73","author":"Lee","year":"1995","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.colsurfb.2019.110446_bib0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BST20130014","article-title":"Mechanisms of microbial escape from phagocyte killing","volume":"41","author":"Smith","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.colsurfb.2019.110446_bib0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/cmi.12394","article-title":"The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation","volume":"17","author":"Smith","year":"2015","journal-title":"Cell. Microbiol."},{"issue":"5","key":"10.1016\/j.colsurfb.2019.110446_bib0060","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1402376","article-title":"Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence","volume":"194","author":"Davis","year":"2015","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.colsurfb.2019.110446_bib0065","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/IAI.00587-07","article-title":"Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice","volume":"75","author":"Kechichian","year":"2007","journal-title":"Infect. Immun."},{"issue":"21","key":"10.1016\/j.colsurfb.2019.110446_bib0070","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cub.2006.09.061","article-title":"Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages","volume":"16","author":"Alvarez","year":"2006","journal-title":"Curr. Biol."},{"issue":"21","key":"10.1016\/j.colsurfb.2019.110446_bib0075","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.cub.2006.09.032","article-title":"Expulsion of live pathogenic yeast by macrophages","volume":"16","author":"Ma","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0080","doi-asserted-by":"crossref","first-page":"21489","DOI":"10.1038\/srep21489","article-title":"Cryptococcus neoformans intracellular proliferation and capsule size determines early macrophage control of infection","volume":"6","author":"Bojarczuk","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.colsurfb.2019.110446_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00167-11","article-title":"Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH","volume":"2","author":"Nicola","year":"2011","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.colsurfb.2019.110446_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.colsurfb.2019.110446_bib0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinids\/2.4.551","article-title":"Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole","volume":"2","author":"Graybill","year":"1980","journal-title":"Rev. Infect. Dis."},{"issue":"26","key":"10.1016\/j.colsurfb.2019.110446_bib0100","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Loyse","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.colsurfb.2019.110446_bib0105","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3201\/eid1001.020779","article-title":"Antifungal susceptibilities of Cryptococcus neoformans","volume":"10","author":"Archibald","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.colsurfb.2019.110446_bib0115","first-page":"696","article-title":"Ketoconazole therapy of murine cryptococcal meningitis","volume":"125","author":"Craven","year":"1982","journal-title":"Am. Rev. Respir. Dis."},{"issue":"8","key":"10.1016\/j.colsurfb.2019.110446_bib0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/1061186X.2017.1331352","article-title":"Potential of novel drug delivery systems in the management of topical candidiasis","volume":"25","author":"Mathur","year":"2017","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.colsurfb.2019.110446_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1139\/cjm-2017-0749","article-title":"The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery","volume":"64","author":"Szalewski","year":"2018","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0130","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IJN.S93105","article-title":"Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?","volume":"11","author":"Voltan","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.colsurfb.2019.110446_bib0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1381612822666161027103640","article-title":"Exploring the role of nanoparticles in amphotericin B delivery","volume":"23","author":"Zaioncz","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0140","article-title":"Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis","author":"Abu Ammar","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.colsurfb.2019.110446_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00631-18","article-title":"Local skin inflammation in cutaneous leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B","volume":"62","author":"Wijnant","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.colsurfb.2019.110446_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.110446_bib0160","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1871524919666181126124846","article-title":"Development and characterization of nasal delivery of selegiline hydrochloride loaded nanolipid carriers for the management of Parkinson\u2019s disease","volume":"19","author":"Mishra","year":"2019","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0170","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.2147\/IJN.S145695","article-title":"Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model","volume":"12","author":"Tian","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.110446_bib0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.colsurfb.2015.02.040","article-title":"Liposomal co-delivery of curcumin and albumin\/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy","volume":"128","author":"Ruttala","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.colsurfb.2019.110446_bib0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.chom.2013.02.002","article-title":"Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence","volume":"13","author":"Ding","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.colsurfb.2019.110446_bib0185","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/JCM.40.10.3841-3844.2002","volume":"40","author":"Chryssanthou","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/mmi.12653","article-title":"Iron and copper as virulence modulators in human fungal pathogens","volume":"93","author":"Ding","year":"2014","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","article-title":"Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges","volume":"523","author":"Soliman","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"15","key":"10.1016\/j.colsurfb.2019.110446_bib0200","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.110446_bib0205","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2017.11.031","article-title":"Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: pharmacokinetic and teratogenic assessment","volume":"108","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","article-title":"Intranasal administration of TAT-Conjugated lipid nanocarriers loading GDNF for parkinson\u2019s disease","volume":"55","author":"Hernando","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.colsurfb.2019.110446_bib0215","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2217\/imt.11.86","article-title":"Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy","volume":"3","author":"Vecchiarelli","year":"2011","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.colsurfb.2019.110446_bib0220","doi-asserted-by":"crossref","first-page":"e180040","DOI":"10.1590\/0074-02760180040","article-title":"Peeling the onion: the outer layers of Cryptococcus neoformans","volume":"113","author":"Agustinho","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.colsurfb.2019.110446_bib0225","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/cmi.12590","article-title":"Cryptococcal therapies and drug targets: the old, the new and the promising","volume":"18","author":"Coelho","year":"2016","journal-title":"Cell. Microbiol."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: the problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.colsurfb.2019.110446_bib0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascul. Pharmacol."},{"issue":"10","key":"10.1016\/j.colsurfb.2019.110446_bib0240","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11095-013-1122-4","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.colsurfb.2019.110446_bib0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2013.06.028","article-title":"Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems","volume":"171","author":"Kozlovskaya","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.110446_bib0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.colsurfb.2019.110446_bib0255","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"2nd, Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519305909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519305909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:44:29Z","timestamp":1760525069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519305909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":51,"alternative-id":["S0927776519305909"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110446","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110446"}}